(19)
(11) EP 3 691 692 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
26.05.2021 Bulletin 2021/21

(45) Mention of the grant of the patent:
30.12.2020 Bulletin 2020/53

(21) Application number: 18797311.0

(22) Date of filing: 12.10.2018
(51) International Patent Classification (IPC): 
A61K 47/68(2017.01)
C07K 16/28(2006.01)
 A61P 35/00(2006.01)
(86) International application number:
PCT/US2018/055733
(87) International publication number:
WO 2019/075417 (18.04.2019 Gazette 2019/16)

(54)

ANTI-CD71 ACTIVATABLE ANTIBODY DRUG CONJUGATES AND METHODS OF USE THEREOF

AKTIVIERBARE ANTI-CD71-ANTIKÖRPER-WIRKSTOFF-KONJUGATE UND VERFAHREN ZUR VERWENDUNG DAVON

CONJUGUÉS DE MÉDICAMENT ANTICORPS ACTIVABLES ANTI-CD71 ET LEURS PROCÉDÉS D'UTILISATION

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 14.10.2017 US 201762572467 P

(43) Date of publication of application:
12.08.2020 Bulletin 2020/33

(60) Divisional application:
20209320.9

(73) Proprietor: AbbVie Inc.
North Chicago, IL 60064 (US)

(72) Inventors:
  • SINGH, Shweta
    South San Francisco, California 94080 (US)
  • RICHARDSON, Jennifer Hope
    South San Francisco, California 94080 (US)
  • SERWER, Laura Patterson
    South San Francisco, California 94080 (US)
  • TERRETT, Jonathan Alexander
    South San Francisco, California 94080 (US)
  • MORGAN-LAPPE, Susan E.
    North Chicago, Illinois 60064 (US)
  • HENRIQUES, Tracy
    North Chicago, Illinois 60064 (US)
  • RALSTON, Sherry L.
    North Chicago, Illinois 60064 (US)
  • LEANNA, Marvin Robert
    North Chicago, Illinois 60064 (US)
  • BADAGNANI, Ilaria
    North Chicago, Illinois 60064 (US)
  • BOSE, Sahana
    North Chicago, Illinois 60064 (US)

(74) Representative: Schlich, George et al
Schlich 9 St Catherine's Road
Littlehampton, West Sussex BN17 5HS
Littlehampton, West Sussex BN17 5HS (GB)


(56) References cited: : 
WO-A2-2016/179257
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).